A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Recruiting · NCT07403188 · Observational (researchers observe without assigning treatment) · Lead sponsor: Kyverna Therapeutics
View the official record on ClinicalTrials.gov →Interventions studied
KYV-101
What this trial is about
The purpose of this long-term follow-up (LTFU) study is to collect delayed adverse events (AEs) and understand the persistence of KYV-101 (autologous CAR T cell product; gene-modified product), in participants who have been administered KYV-101 (gene-modified product; autologous CAR T cell product). This LTFU protocol will be open to any participant who received at least one infusion of KYV-101 in a previous Kyverna sponsored clinical trial or Investigator Initiated Trial (IIT).
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Provided informed consent for the LTFU study
- Received at least 1 infusion of KYV-101 as part of a previous KYV-101 parent treatment protocol
Exclusion criteria
- Not applicable
Where it is running
1 location listed across 1 US state.
- University of Colorado, Denver - Denver, Colorado, United States